Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
48.29 CAD | +3.01% | -0.31% | -24.41% |
13/05 | Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating | MT |
10/05 | National Bank Reviews Docebo's Q1 -- Trims Target to US$55 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.41% | 1.04B | |
+9.22% | 3,085B | |
+7.89% | 85.92B | |
+4.01% | 77.91B | |
-16.81% | 52.89B | |
+22.89% | 48.28B | |
+28.71% | 45.38B | |
-33.82% | 40.83B | |
+69.94% | 38.78B | |
+0.43% | 27.48B |
- Stock Market
- Equities
- DCBO Stock
- News Docebo Inc.
- Docebo Brief: For Q1, Sees Total revenue between US$52.2 and $52.4 million; Adjusted EBITDA as a percentage of total revenue between 14.0% to 15.0%